103 related articles for article (PubMed ID: 24901819)
1. Serum antibodies to microbial antigens for Crohn's disease progression: a meta-analysis.
Xiong Y; Wang GZ; Zhou JQ; Xia BQ; Wang XY; Jiang B
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):733-42. PubMed ID: 24901819
[TBL] [Abstract][Full Text] [Related]
2. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
3. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
4. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
5. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.
Dubinsky MC; Lin YC; Dutridge D; Picornell Y; Landers CJ; Farrior S; Wrobel I; Quiros A; Vasiliauskas EA; Grill B; Israel D; Bahar R; Christie D; Wahbeh G; Silber G; Dallazadeh S; Shah P; Thomas D; Kelts D; Hershberg RM; Elson CO; Targan SR; Taylor KD; Rotter JI; Yang H;
Am J Gastroenterol; 2006 Feb; 101(2):360-7. PubMed ID: 16454844
[TBL] [Abstract][Full Text] [Related]
6. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease.
Spivak J; Landers CJ; Vasiliauskas EA; Abreu MT; Dubinsky MC; Papadakis KA; Ippoliti A; Targan SR; Fleshner PR
Inflamm Bowel Dis; 2006 Dec; 12(12):1122-30. PubMed ID: 17119386
[TBL] [Abstract][Full Text] [Related]
9. High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease.
Yu JE; De Ravin SS; Uzel G; Landers C; Targan S; Malech HL; Holland SM; Cao W; Harpaz N; Mayer L; Cunningham-Rundles C
Clin Immunol; 2011 Jan; 138(1):14-22. PubMed ID: 20956091
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis.
Tyler AD; Milgrom R; Xu W; Stempak JM; Steinhart AH; McLeod RS; Greenberg GR; Cohen Z; Silverberg MS
Clin Gastroenterol Hepatol; 2012 May; 10(5):507-12.e1. PubMed ID: 21963956
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
12. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
[TBL] [Abstract][Full Text] [Related]
13. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
Landers CJ; Cohavy O; Misra R; Yang H; Lin YC; Braun J; Targan SR
Gastroenterology; 2002 Sep; 123(3):689-99. PubMed ID: 12198693
[TBL] [Abstract][Full Text] [Related]
14. Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase.
Suzuki H; Fukuda Y; Koizuka H; Tomita T; Hori K; Suzuki M; O'Morain C
Am J Gastroenterol; 2008 Mar; 103(3):656-64. PubMed ID: 18028509
[TBL] [Abstract][Full Text] [Related]
15. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study.
Wallis D; Asaduzzaman A; Weisman M; Haroon N; Anton A; McGovern D; Targan S; Inman R
Arthritis Res Ther; 2013 Oct; 15(5):R166. PubMed ID: 24286190
[TBL] [Abstract][Full Text] [Related]
17. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
18. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients.
Amre DK; Lu SE; Costea F; Seidman EG
Am J Gastroenterol; 2006 Mar; 101(3):645-52. PubMed ID: 16464223
[TBL] [Abstract][Full Text] [Related]
19. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
